Clinical Trial Supplies Market: Global Industry Research Report 2020-2027 | Envisage Research
Envisage report cover

Clinical Trial Supplies Market - By Products and Services (Manufacturing, Packaging, Logistics, And Distribution), By Phase (Phase I, Phase II, Phase III, Phase IV, BA/BE Studies), By Therapeutic Area (Oncology, Cardiovascular Diseases, Neurological Diseases, Respiratory Diseases, Orthopaedics, And Others), And By Region (North America, Asia Pacific, Europe, Middle East & Africa and Latin America) - Industry Analysis, opportunity and Forecast 2020 To 2027

Published Date: May 2021

No. of Pages: 189

Status: Published

Report Code: EMR100681

The Clinical Trial Supplies Market is projected to reach USD 2.82 billion by 2027 from USD 1.70 billion in 2020, at a CAGR of 7.5 %. The growth of this market is majorly driven by the increasing R&D expenditure in pharmaceutical and biopharmaceutical companies and the globalization of clinical trials & harmonization of regulations. A safe clinical trial presupposes a robust supply chain management of the study drugs, consistent with various regional and global regulations and available infrastructures. Clinical trial supplies management is imperative for avoiding overproduction, inventory expiration, and oversupply. With the escalating costs of drug discovery, clinical trial supplies are gaining more significance. In addition, the implementation of stricter handling requirements for a variety of biopharmaceutical products entering clinical trials, clinical trial supplies strategy needs to be constantly overhauled. This also calls for integrating several third-party vendors across all stages of clinical development.

Sponsors and contract research organizations partaking drug discovery initiatives have realized the role of clinical trials logistics and end-to-end solutions for respecting the desired study timelines. Stringent handling requirements pertaining to the handling requirements such as good manufacturing practices (GMP) are essential for the manufacture, storage, and distribution of investigational medicinal products (IMPs), essentially for clinical trials being conducted in developed regions such as Europe and North America. Activities related to import and distribution of IMPs and Non-Investigational Products (NIMPs) also mandate an extensive clinical trial supplies planning for adhering to require trial protocols. These also include standardized return and destruction procedures. The increasing prevalence of chronic diseases such as various cancer types and the growing popularity outsourcing of drug discovery services, in several developing and developed nations, is expected to bolster the demand for clinical trial supplies services. In addition, the rising need for determining the level of toxicity in the early stages of drug discovery is a crucial factor catalysing the clinical trial supplies market.

Clinical trials are research studies that discover whether a medical treatment, strategy, or device is effective and safe for humans. There are four stages of clinical trials: phase Ι, phase ΙΙ, phase ΙΙΙ, and phase ΙV. Identification of pharmacological actions and tolerability is done in phase I. Phase ΙΙ evaluates drug safety and efficacy. Phase III involves the evaluation of risk benefit ratio and determination of dosage interval. Epidemiological data, efficacy, and safety within large diverse populations and Pharmacoeconomics are identified in phase IV.

Clinical trials are complex activities that require synchronization of several different functions and processes. A pharmaceutical manufacturer’s primary goal in any clinical study is to optimize clinical trial supplies so that packaged investigational materials are distributed to patients enrolled in a clinical trial on time. These activities include, but are not limited to, project management, clinical packaging, randomization generation, labelling, supply chain logistics, blinding, distribution, return drug accountability, and destruction.

The prominent players operating in the global clinical trial supplies market include Alamc Group (UK), Catalent, Inc. (US), PCI Services (US), Parexel International Corporation (US), Sharp Packaging Services (US), Biocair (UK), O&M Movianto (US), KLIFO A/S (Denmark), and Thermo Fisher Scientific, Inc. (US).
Catalent, Inc. (US) is the leading player in the global market. The company has an extensive network that provides comprehensive services to various pharmaceutical companies for phase I-IV clinical trials. Catalent’s offerings in the market include forecasting and planning services, packaging services, comparator sourcing, and distribution and logistics services. In 2018, Catalent generated ~51% of its total revenue from the US. Also, the company is focusing on increasing its customer base and expanding its reach in untapped APAC markets

Analyst Commentary

The global clinical trials supply market is witnessing strong growth due to the increasing prevalence of chronic diseases such as cancer, epilepsy, and HIV; rising demand for outsourcing of drug discovery services, and increased emphasis on determining toxicity level in early stages of drug discovery. The growth of this market is majorly driven by the increasing R&D expenditure in pharmaceutical and biopharmaceutical companies and the globalization of clinical trials & harmonization of regulations. On the basis of service, the logistics services segment is expected to dominate this market during the forecast period owing to the globalization of clinical trials and the increasing number of clinical trials involving temperature-sensitive products. However, the comparator sourcing services segment is estimated to grow at the highest CAGR during the forecast period.

On the basis of phase, phase III segment is expected to account for the largest share of the market in 2020 and is estimated to grow at the highest CAGR during the forecast period. The large share and high growth of this segment can be attributed to the fact that phase III trials are the most expensive, time-consuming, and difficult to design and run.

Segmentation

The clinical trial supplies market can be segmented based on products and services, phase, therapeutic area, and region. In terms of products and services, the market can be categorized into manufacturing, packaging, logistics, and distribution. Based on therapeutic area, the clinical trial supply market can be segmented into oncology, cardiovascular diseases, neurological diseases, respiratory diseases, orthopaedics, and others. Based on phase the market is bifurcated into Phase I, Phase II, Phase III, Phase IV, BA/BE Studies. In terms of region, the market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Regional Analysis

North America accounted for the largest share of the clinical trial supplies market due to high number of research and development activities in the area of drug discovery, advanced health care infrastructure, and presence of multinational pharmaceutical and biotechnology companies that carry out clinical trials. Europe accounted for the second largest share in terms of revenue owing to high health care investment and rising government funding. Asia Pacific is also witnessing significant growth due to rising unmet health care needs and increased government funding to research activities.

Moreover, major pharmaceutical companies are outsourcing their drug development services to various countries such as China, Singapore, Malaysia, and India, which is propelling the growth of the clinical trial supplies market in the region. Middle East and Latin America are expected to be the prospective markets due growing access to information, high cancer burden, improving patient education, and access to new drugs for research centers. However, long timeline for regulatory approval, lack of training, lack of economic investment, and lack of personnel participating in clinical research in Latin America and Middle East are expected to restrain the clinical trial supplies market.

TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data Products & Servicess
2.3.1. Secondary Products & Servicess
2.3.1.1. Preliminary data mining
2.3.2. Primary Products & Servicess
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Global Clinical Supplies Trial Market
Chapter 5. Global Clinical Supplies Trial Market Overview, By Products & Services, 2015 - 2027 (USD Million)
5.1. Global Clinical Supplies Trial Market Share, By Products & Services, 2015 - 2027 (USD Million)
5.1.1. Manufacturing
5.1.1.1. Market Size and Projections,2015 - 2027 (USD Million)
5.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.2. Packaging
5.1.2.1. Market Size and Projections, 2015 - 2027 (USD Million)
5.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.3. Logistics
5.1.3.1. Market Size and Projections, 2015 - 2027 (USD Million)
5.1.3.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.4. Distribution
5.1.4.1. Market Size and Projections, 2015 - 2027 (USD Million)
5.1.4.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 6. Global Clinical Supplies Trial Market Overview, By Therapeutic Area, 2015 - 2027 (USD Million)
6.1. Global Clinical Supplies Trial Share, By Therapeutic Area, 2015 - 2027 (USD Million)
6.1.1. Oncology
6.1.1.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
6.1.2. Cardiovascular Diseases
6.1.2.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
6.1.3. Neurological Diseases
6.1.3.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.3.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
6.1.4. Respiratory Diseases
6.1.4.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.4.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
6.1.5. Orthopaedics
6.1.5.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.5.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
6.1.6. Phase BA/BE
6.1.6.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.6.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 7. Global Clinical Supplies Trial Market Overview, By Phase, 2015 - 2027 (USD Million)
7.1. Global Clinical Supplies Trial Share, By Phase, 2015 - 2027 (USD Million)
7.1.1. Phase 1
7.1.1.1. Market Size and Projections, 2015 - 2027 (USD Million)
7.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
7.1.2. Phase 2
7.1.2.1. Market Size and Projections, 2015 - 2027 (USD Million)
7.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
7.1.3. Phase 3
7.1.3.1. Market Size and Projections, 2015 - 2027 (USD Million)
7.1.3.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
7.1.4. Phase 4
7.1.4.1. Market Size and Projections, 2015 - 2027 (USD Million)
7.1.4.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
7.1.5. Phase BA/BE
7.1.5.1. Market Size and Projections, 2015 - 2027 (USD Million)
7.1.5.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 8. Global Clinical Supplies Trial Market Overview, By Geography, 2015 – 2027 (USD Million)
8.1. Global Clinical Supplies Trial Market Share, By Geography, 2015 - 2027 (USD Million)
8.1.1. Market Size and projections, by Countries, 2015 – 2027 (USD Million)
8.1.2. Market Share and CAGR Comparison, by Countries, 2019 (%)
Chapter 9. North America Clinical Supplies Trial Market Overview, By Countries, 2015 - 2027 (USD Million)
9.1. North America Global Clinical Supplies Trial Market Overview, 2015 - 2027 (USD Million)
9.1.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.2. North America Clinical Supplies Trial Market Overview, By Products & Services, 2015 - 2027 (USD Million)
9.1.3. North America Clinical Supplies Trial Market Overview, By Therapeutic Area, 2015 - 2027 (USD Million)
9.1.4. North America Clinical Supplies Trial Market Overview, By Phase, 2015 - 2027 (USD Million)
9.1.5. North America Clinical Supplies Trial Market Overview, By Countries, 2015 - 2027 (USD Million)
9.1.5.1. U.S. Clinical Supplies Trial Market Overview, 2015 - 2027 (USD Million)
9.1.5.1.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.5.1.2. U.S. Clinical Supplies Trial Market Overview, By Products & Services, 2015 - 2027 (USD Million)
9.1.5.1.3. U.S. Clinical Supplies Trial Market Overview, By Therapeutic Area, 2015 - 2027 (USD Million)
9.1.5.1.4. U.S. Clinical Supplies Trial Market Overview, By Phase, 2015 - 2027 (USD Million)
9.1.5.2. Canada Clinical Supplies Trial Market Overview, 2015 - 2027 (USD Million)
9.1.5.2.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.5.2.2. Canada Clinical Supplies Trial Market Overview, By Products & Services, 2015 - 2027 (USD Million)
9.1.5.2.3. Canada Clinical Supplies Trial Market Overview, By Therapeutic Area, 2015 - 2027 (USD Million)
9.1.5.2.4. Canada Clinical Supplies Trial Market Overview, By Phase, 2015 - 2027 (USD Million)
9.1.5.3. Mexico Clinical Supplies Trial Market Overview, 2015 - 2027 (USD Million)
9.1.5.3.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.5.3.2. Mexico Clinical Supplies Trial Market Overview, By Products & Services, 2015 - 2027 (USD Million)
9.1.5.3.3. Mexico Clinical Supplies Trial Market Overview, By Therapeutic Area, 2015 - 2027 (USD Million)
9.1.5.3.4. Mexico Clinical Supplies Trial Market Overview, By Phase, 2015 - 2027 (USD Million)
Chapter 10. Europe Clinical Supplies Trial Market Overview, By Countries, 2015 - 2027 (USD Million)
10.1. Europe Clinical Supplies Trial Market Overview, 2015 – 2027 (USD Million)
10.1.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.2. Europe Clinical Supplies Trial Market Overview, By Products & Services, 2015 - 2027 (USD Million)
10.1.3. Europe Clinical Supplies Trial Market Overview, By Therapeutic Area, 2015 - 2027 (USD Million)
10.1.4. Europe Clinical Supplies Trial Market Overview, By Phase, 2015 - 2027 (USD Million)
10.1.5. Europe Clinical Supplies Trial Market Overview, By Countries, 2015 - 2027 (USD Million)
10.1.5.1. Germany
10.1.5.1.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.5.1.2. Germany Clinical Supplies Trial Market Overview, By Products & Services, 2015 - 2027 (USD Million)
10.1.5.1.3. Germany Clinical Supplies Trial Market Overview, By Therapeutic Area, 2015 - 2027 (USD Million)
10.1.5.1.4. Germany Clinical Supplies Trial Market Overview, By Phase, 2015 - 2027 (USD Million)
10.1.5.2. France
10.1.5.2.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.5.2.2. France Clinical Supplies Trial Market Overview, By Products & Services, 2015 - 2027 (USD Million)
10.1.5.2.3. France Clinical Supplies Trial Market Overview, By Therapeutic Area, 2015 - 2027 (USD Million)
10.1.5.2.4. France Clinical Supplies Trial Market Overview, By Phase, 2015 - 2027 (USD Million)
10.1.5.3. UK
10.1.5.3.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.5.3.2. UK Clinical Supplies Trial Market Overview, By Products & Services, 2015 - 2027 (USD Million)
10.1.5.3.3. UK Clinical Supplies Trial Market Overview, By Therapeutic Area, 2015 - 2027 (USD Million)
10.1.5.3.4. UK Clinical Supplies Trial Market Overview, By Phase, 2015 - 2027 (USD Million)
10.1.5.4. Italy
10.1.5.4.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.5.4.2. Italy Clinical Supplies Trial Market Overview, By Products & Services, 2015 - 2027 (USD Million)
10.1.5.4.3. Italy Clinical Supplies Trial Market Overview, By Therapeutic Area, 2015 - 2027 (USD Million)
10.1.5.4.4. Italy Clinical Supplies Trial Market Overview, By Phase, 2015 - 2027 (USD Million)
10.1.5.5. Spain
10.1.5.5.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.5.5.2. Spain Clinical Supplies Trial Market Overview, By Products & Services, 2015 - 2027 (USD Million)
10.1.5.5.3. Spain Clinical Supplies Trial Market Overview, By Therapeutic Area, 2015 - 2027 (USD Million)
10.1.5.5.4. Spain Clinical Supplies Trial Market Overview, By Phase, 2015 - 2027 (USD Million)
10.1.5.6. Rest of Europe
10.1.5.6.1. Market size and projections, 2015 – 2025
10.1.5.6.2. Rest of Europe Clinical Supplies Trial Market Overview, By Products & Services, 2015 - 2027 (USD Million)
10.1.5.6.3. Rest of Europe Clinical Supplies Trial Market Overview, By Therapeutic Area, 2015 - 2027 (USD Million)
10.1.5.6.4. Rest of Europe Clinical Supplies Trial Market Overview, By Phase, 2015 - 2027 (USD Million)
Chapter 11. Asia Pacific Clinical Supplies Trial Market Overview, By Countries, 2015 - 2027 (USD Million)
11.1. Asia Pacific Clinical Supplies Trial Market Overview, 2015 - 2027 (USD Million)
11.1.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.2. Asia Pacific Clinical Supplies Trial Market Overview, By Products & Services, 2015 - 2027 (USD Million)
11.1.3. Asia Pacific Clinical Supplies Trial Market Overview, By Therapeutic Area, 2015 - 2027 (USD Million)
11.1.4. Asia Pacific Clinical Supplies Trial Market Overview, By Phase, 2015 - 2027 (USD Million)
11.1.5. Asia Pacific Clinical Supplies Trial Market Overview, By Countries, 2015 - 2027 (USD Million)
11.1.5.1. India
11.1.5.1.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.5.1.2. India Clinical Supplies Trial Market Overview, By Products & Services, 2015 - 2027 (USD Million)
11.1.5.1.3. India Clinical Supplies Trial Market Overview, By Therapeutic Area, 2015 - 2027 (USD Million)
11.1.5.1.4. India Clinical Supplies Trial Market Overview, By Phase, 2015 - 2027 (USD Million)
11.1.5.2. China
11.1.5.2.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.5.2.2. China Clinical Supplies Trial Market Overview, By Products & Services, 2015 - 2027 (USD Million)
11.1.5.2.3. China Clinical Supplies Trial Market Overview, By Therapeutic Area, 2015 - 2027 (USD Million)
11.1.5.2.4. China Clinical Supplies Trial Market Overview, By Phase, 2015 - 2027 (USD Million)
11.1.5.3. Japan
11.1.5.3.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.5.3.2. Japan Clinical Supplies Trial Market Overview, By Products & Services, 2015 - 2027 (USD Million)
11.1.5.3.3. Japan Clinical Supplies Trial Market Overview, By Therapeutic Area, 2015 - 2027 (USD Million)
11.1.5.3.4. Japan Clinical Supplies Trial Market Overview, By Phase, 2015 - 2027 (USD Million)
11.1.5.4. South Korea
11.1.5.4.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.5.4.2. South Korea Clinical Supplies Trial Market Overview, By Products & Services, 2015 - 2027 (USD Million)
11.1.5.4.3. South Korea Clinical Supplies Trial Market Overview, By Therapeutic Area, 2015 - 2027 (USD Million)
11.1.5.4.4. South Korea Clinical Supplies Trial Market Overview, By Phase, 2015 - 2027 (USD Million)
11.1.5.5. Rest of Asia Pacific
11.1.5.5.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.5.5.2. Rest of Asia Pacific Clinical Supplies Trial Market Overview, By Products & Services, 2015 - 2027 (USD Million)
11.1.5.5.3. Rest of Asia Pacific Clinical Supplies Trial Market Overview, By Therapeutic Area, 2015 - 2027 (USD Million)
11.1.5.5.4. Rest of Asia Pacific Clinical Supplies Trial Market Overview, By Phase, 2015 - 2027 (USD Million)
Chapter 12. Middle East & Africa Global Clinical Supplies Trial Market Overview, By Countries, 2015 - 2027 (USD Million)
12.1. Middle East & Africa Clinical Supplies Trial Market Overview, 2015 - 2027 (USD Million)
12.1.1. Market size and projections, 2015 - 2027 (USD Million)
12.1.2. Middle East & Africa Clinical Supplies Trial Market Overview, By Products & Services, 2015 - 2027 (USD Million)
12.1.3. Middle East & Africa Clinical Supplies Trial Market Overview, By Therapeutic Area, 2015 - 2027 (USD Million)
12.1.4. Middle East & Africa Clinical Supplies Trial Market Overview, By Phase, 2015 - 2027 (USD Million)
12.1.5. Middle East & Africa Clinical Supplies Trial Market Overview, By Countries, 2015 - 2027 (USD Million)
12.1.5.1. GCC
12.1.5.1.1. Market size and projections, 2015 - 2027 (USD Million)
12.1.5.1.2. GCC Clinical Supplies Trial Market Overview, By Products & Services, 2015 - 2027 (USD Million)
12.1.5.1.3. GCC Clinical Supplies Trial Market Overview, By Therapeutic Area, 2015 - 2027 (USD Million)
12.1.5.1.4. GCC Clinical Supplies Trial Market Overview, By Phase, 2015 - 2027 (USD Million)
12.1.5.2. South Africa
12.1.5.2.1. Market size and projections, 2015 - 2027 (USD Million)
12.1.5.2.2. South Africa Clinical Supplies Trial Market Overview, By Products & Services, 2015 - 2027 (USD Million)
12.1.5.2.3. South Africa Clinical Supplies Trial Market Overview, By Therapeutic Area, 2015 - 2027 (USD Million)
12.1.5.2.4. South Africa Clinical Supplies Trial Market Overview, By Phase, 2015 - 2027 (USD Million)
12.1.5.3. Rest of Middle East & Africa
12.1.5.3.1. Market size and projections, 2015 - 2027 (USD Million)
12.1.5.3.2. Rest of Middle East & Africa Clinical Supplies Trial Market Overview, By Products & Services, 2015 - 2027 (USD Million)
12.1.5.3.3. Rest of Middle East & Africa Clinical Supplies Trial Market Overview, By Therapeutic Area, 2015 - 2027 (USD Million)
12.1.5.3.4. Rest of Middle East & Africa Clinical Supplies Trial Market Overview, By Phase, 2015 - 2027 (USD Million)
Chapter 13. South America Global Clinical Supplies Trial Market Overview, By Countries, 2015 - 2027 (USD Million)
13.1. South America Clinical Supplies Trial Market Overview, 2015 - 2027 (USD Million)
13.1.1. Market size and projections, 2015 - 2027 (USD Million)
13.1.2. South America Clinical Supplies Trial Market Overview, By Products & Services, 2015 - 2027 (USD Million)
13.1.3. South America Clinical Supplies Trial Market Overview, By Therapeutic Area, 2015 - 2027 (USD Million)
13.1.4. South America Clinical Supplies Trial Market Overview, By Phase, 2015 - 2027 (USD Million)
13.1.5. South America Clinical Supplies Trial Market Overview, By Countries, 2015- 2026 (USD Million)
13.1.5.1. Brazil
13.1.5.1.1. Market size and projections, 2015 - 2027 (USD Million)
13.1.5.1.2. Brazil Clinical Supplies Trial Market Overview, By Products & Services, 2015 - 2027 (USD Million)
13.1.5.1.3. Brazil Clinical Supplies Trial Market Overview, By Therapeutic Area, 2015 - 2027 (USD Million)
13.1.5.1.4. Brazil Clinical Supplies Trial Market Overview, By Phase, 2015 - 2027 (USD Million)
13.1.5.2. Argentina
13.1.5.2.1. Market size and projections, 2015 - 2027 (USD Million)
13.1.5.2.2. Argentina Clinical Supplies Trial Market Overview, By Products & Services, 2015 - 2027 (USD Million)
13.1.5.2.3. Argentina Clinical Supplies Trial Market Overview, By Therapeutic Area, 2015 - 2027 (USD Million)
13.1.5.2.4. Argentina Clinical Supplies Trial Market Overview, By Phase, 2015 - 2027 (USD Million)
13.1.5.3. Rest of South America
13.1.5.3.1. Market size and projections, 2015 – 2026
13.1.5.3.2. Rest of South America Clinical Supplies Trial Market Overview, By Products & Services, 2015 - 2027 (USD Million)
13.1.5.3.3. Rest of South America Clinical Supplies Trial Market Overview, By Therapeutic Area, 2015 - 2027 (USD Million)
13.1.5.3.4. Rest of South America Clinical Supplies Trial Market Overview, By Phase, 2015 - 2027 (USD Million)
Chapter 14. Competitive Landscape
14.1. Competitive environment, 2020
14.2. Strategic framework
14.2.1. Partnership/agreement
14.2.2. Expansion
14.2.3. Mergers & Acquisitions
14.2.4. New Products & Services & Manufacturing
Chapter 15. Key Player Analysis
15.1. Alamc
15.1.1. Company overview
15.1.2. Financial performance
15.1.3. Products & Services & Manufacturing Benchmarking
15.1.4. Recent initiatives
15.1.5. SWOT analysis
15.2. Catalent Inc.
15.2.1. Company overview
15.2.2. Financial performance
15.2.3. Products & Services & Manufacturing Benchmarking
15.2.4. Recent initiatives
15.2.5. SWOT analysis
15.3. PCI Services
15.4. PCI Services
15.5. Paraxel International
15.6. Sharp Packaging Services
15.7. Biociar
15.8. O&M Movianto
15.9. KLIFO A/S
15.10. Thermo Ficher scientific Inc.
Chapter 16. Global Clinical Supplies Trial Market Cost Analysis
16.1. Global Clinical Supplies Trial Market Key Raw Products & Services Analysis
16.1.1. Key Raw Products & Services
16.1.2. NEUROLOGY Trend of Key Raw Products & Services
16.1.3. Key Suppliers of Raw Products & Services
16.1.4. Market Concentration Rate of Raw Products & Services
16.2. Proportion of Wing Cost Structure
16.2.1. Raw Products & Services
16.2.2. Labor Cost
16.2.3. Wing Expenses
16.3. Wing Process Analysis of Unsaturated Polyester Resin (UPR) for Composites
Chapter 17. Chain, Sourcing Strategy and Downstream Buyers
17.1. Global Clinical Supplies Trial Market Chain Analysis
17.2. Upstream Raw Products & Services Sourcing
17.3. Raw Products & Services of Global Clinical Supplies Trial Market Major Manufacturers in 2019
17.4. Downstream Buyers
Chapter 18. Marketing Strategy Analysis, Distributors/Traders
18.1. Marketing Channel
18.1.1. Direct Marketing
18.1.2. Indirect Marketing
18.1.3. Marketing Channel Development Trend
18.2. Market Positioning
18.2.1. Pricing Strategy
18.2.2. Brand Strategy
18.2.3. Target Electrical Damage
18.3. Distributors/Traders List
Chapter 19. Market Effect Factors Analysis
19.1. Products & Services & Manufacturing Progress/Risk
19.1.1. Substitutes Threat
19.1.2. Products & Services & Manufacturing Progress in Related Products & Services
19.2. Manufacturing Needs/Customer Preference Change
19.3. Economic/Political Environmental Change
Chapter 20. Future Outlook of the Market
Disclaimer

List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Clinical Supplies Trial Market share, by Products & Services, 2020 & 2027 (%)
10. Global Clinical Supplies Trial Market share, by Manufacturing, by Products & Services, 2020 & 2027 (USD Million)
11. Global Clinical Supplies Trial Market share, by Packaging, by Products & Services, 2020 & 2027 (USD Million)
12. Global Clinical Supplies Trial Market share, by Logistics, by Products & Services, 2020 & 2027 (USD Million)
13. Global Clinical Supplies Trial Market share, by Distribution, by Products & Services, 2020 & 2027 (USD Million)
14. Global Clinical Supplies Trial Market share, by Therapeutic Area, 2020 & 2027 (%)
15. Global Clinical Supplies Trial Market share, by Oncology, by Therapeutic Area, 2020 & 2027 (USD Million)
16. Global Clinical Supplies Trial Market share, by Cardiovascular Diseases, by Therapeutic Area, 2020 & 2027 (USD Million)
17. Global Clinical Supplies Trial Market share, by Neurological Diseases, by Therapeutic Area, 2020 & 2027 (USD Million)
18. Global Clinical Supplies Trial Market share, by Respiratory Diseases, by Therapeutic Area, 2020 & 2027 (USD Million)
19. Global Clinical Supplies Trial Market share, by Orthopaedics, by Therapeutic Area, 2020 & 2027 (USD Million)
20. Global Clinical Supplies Trial Market share, by Others, by Therapeutic Area, 2020 & 2027 (USD Million)
21. Global Clinical Supplies Trial Market share, by Phase, 2020 & 2027 (%)
22. Global Clinical Supplies Trial Market share, by Phase 1, by Phase, 2020 & 2027 (USD Million)
23. Global Clinical Supplies Trial Market share, by Phase 2, by Phase, 2020 & 2027 (USD Million)
24. Global Clinical Supplies Trial Market share, by Phase 3, by Phase, 2020 & 2027 (USD Million)
25. Global Clinical Supplies Trial Market share, by Phase 4, by Phase, 2020 & 2027 (USD Million)
26. Global Clinical Supplies Trial Market share, by region, 2020 - 2027(%)
27. Global Clinical Supplies Trial Market share, by region, 2019 - 2027(USD Million)
28. North America Global Clinical Supplies Trial Market, 2020 - 2027(USD Million)
29. North America Global Clinical Supplies Trial Market share, by Countries, 2020 & 2027 (%)
30. U.S. Global Clinical Supplies Trial Market, 2020 - 2027(USD Million)
31. Canada Global Clinical Supplies Trial Market, 2020 - 2027(USD Million)
32. Europe Global Clinical Supplies Trial Market, 2020 - 2027(USD Million)
33. Europe Global Clinical Supplies Trial Market share, by Countries, 2020 & 2027 (%)
34. Spain Global Clinical Supplies Trial Market, 2020 - 2027(USD Million)
35. UK Global Clinical Supplies Trial Market, 2020 - 2027(USD Million)
36. Italy Global Clinical Supplies Trial Market, 2020 - 2027(USD Million)
37. Germany Global Clinical Supplies Trial Market, 2020 - 2027(USD Million)
38. France Global Clinical Supplies Trial Market, 2020 - 2027(USD Million)
39. Rest of Europe Global Clinical Supplies Trial Market, 2020 - 2027(USD Million)
40. Asia-Pacific Global Clinical Supplies Trial Market, 2020 - 2027(USD Million)
41. Asia-Pacific Global Clinical Supplies Trial Market share, by Countries, 2020 & 2027 (%)
42. China Global Clinical Supplies Trial Market, 2020 - 2027(USD Million)
43. India Global Clinical Supplies Trial Market, 2020 - 2027(USD Million)
44. Australia Global Clinical Supplies Trial Market, 2020 - 2027(USD Million)
45. Japan Global Clinical Supplies Trial Market, 2020 - 2027(USD Million)
46. Rest of Asia-Pacific Global Clinical Supplies Trial Market, 2020 - 2027(USD Million)
47. Middle East & Africa Global Clinical Supplies Trial Market, 2020 - 2027(USD Million)
48. Middle East & Africa Global Clinical Supplies Trial Market share, by Countries, 2020 & 2027 (%)
49. GCC Global Clinical Supplies Trial Market, 2020 - 2027(USD Million)
50. South Africa Global Clinical Supplies Trial Market, 2020 - 2027(USD Million)
51. Rest of Middle East & Africa Global Clinical Supplies Trial Market, 2020 - 2027(USD Million)
52. South America Global Clinical Supplies Trial Market, 2020 - 2027(USD Million)
53. Brazil Global Clinical Supplies Trial Market, 2020 - 2027(USD Million)
54. Mexico Global Clinical Supplies Trial Market, 2020 - 2027(USD Million)
55. Argentina Global Clinical Supplies Trial Market, 2020 - 2027(USD Million)
56. Rest Of South America Global Clinical Supplies Trial Market, 2020 - 2027(USD Million)

List of Tables

1. Impact of Market drivers
2. Impact of Market restraints
3. Global Clinical Supplies Trial Market, 2020-2027 (USD Million)
4. Clinical Supplies Trial requirement, by country, 2020-2027, (USD Million)
5. North America Clinical Supplies Trial Market, By Products & Services, 2020-2027 (USD Million)
6. North America Clinical Supplies Trial Market, by Therapeutic Area, 2020-2027 (USD Million)
7. North America Clinical Supplies Trial Market, by Phase, 2020-2027 (USD Million)
8. Europe Clinical Supplies Trial Market, By Products & Services, 2020-2027 (USD Million)
9. Europe Clinical Supplies Trial Market, by Therapeutic Area, 2020-2027 (USD Million)
10. Europe Clinical Supplies Trial Market, by Phase, 2020-2027 (USD Million)
11. Asia Pacific Clinical Supplies Trial Market, By Products & Services, 2020-2027 (USD Million)
12. Asia Pacific Clinical Supplies Trial Market, by Therapeutic Area, 2020-2027 (USD Million)
13. Asia Pacific Clinical Supplies Trial Market, by Phase, 2020-2027 (USD Million)
14. Middle East & Africa Global Clinical Supplies Trial Market, By Products & Services, 2020-2027 (USD Million)
15. Middle East & Africa Clinical Supplies Trial Market, by Therapeutic Area, 2020-2027 (USD Million)
16. Middle East & Africa Clinical Supplies Trial Market, by Phase, 2020-2027 (USD Million)
17. South America Clinical Supplies Trial Market, By Products & Services, 2020-2027 (USD Million)
18. South America Clinical Supplies Trial Market, by Therapeutic Area, 2020-2027 (USD Million)
19. South America Clinical Supplies Trial Market, by Phase, 2020-2027 (USD Million)
20. Global Clinical Supplies Trial Market, Company Market Share, 2018 (%)
21. Alamc: Product Benchmarking
22. Alamc: Financial Performance
23. Catalent Inc., Product Benchmarking
24. Catalent Inc., Financial Performance
25. PCI Services: Product Benchmarking
26. PCI Services: Financial Performance
27. Paraxel International: Product Benchmarking
28. Paraxel International: Financial Performance
29. Sharp packaging services: Product Benchmarking
30. Sharp packaging services: Financial Performance
31. Biociar: Product Benchmarking
32. Biociar: Financial Performance
33. O&M Movianto : Product Benchmarking
34. O&M Movianto : Financial Performance
35. KLIFO A/S: Product Benchmarking
36. KLIFO A/S: Financial Performance
37. Thermo Fischer Scientific Inc.: Product Benchmarking
38. Thermo Fischer Scientific Inc.: Financial Performance

The Leading Key Players in Clinical Trial Supplies Market

Alamc Group (UK)
Catalent Inc. (US)
PCI Services (US)
Parexel International Corporation (US)
Sharp Packaging Services (US)
Biocair (UK)
O&M Movianto (US)
KLIFO A/S (Denmark)
Thermo Fisher Scientific Inc. (US).